Vicore Pharma Holding AB | |
Stock Exchange | First North Sweden |
EPS |
SEK0.51 |
Market Cap |
SEK308.64 M |
Shares Outstanding |
15.87 M |
Public Float |
- |
Address |
Bioventurehub Mölndal VG 431 83 Sweden |
Employees | - |
Website | http://www.vicorepharma.com |
Updated | 09/14/2018 |
Vicore Pharma Holding AB is a drug development company, which engages in the development of molecules. It designs, synthesizes, and patents a collection of small non-peptide molecules including anti-inflammation, nerve generation and cardiovascular disease. The company was founded in 2005 and is headquartered in Molndal, Sweden. |